SEC Form 4 · accession 0001104659-17-072514
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward F Smith
Officer — CFO
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $6.19 | Dec 6, 2017 | A | 200,000 | A | — | Dec 6, 2027 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/1/2018.